Engagement Strategies for Adolescent Violence Prevention
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine the preliminary efficacy (via a micro-randomized trial \[MRT\] design) of augmenting Enhanced-Replicating Effective Program (E-REP) with engagement strategies to increase and sustain reach by healthcare providers (e.g., nurses, social workers) during implementation of the SafERteens program across multiple healthcare settings.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Engagement Strategies for Adolescent Violence Prevention?
The study on a two-week psychosocial intervention showed that such interventions can reduce future aggression and incarceration in aggressive juvenile offenders, suggesting that structured programs like SafERteens may be effective in violence prevention. Additionally, higher intervention dosage was linked to positive changes in parenting practices in a family-focused violence prevention program, indicating that consistent engagement in similar interventions could be beneficial.12345
How does the Engagement Strategies for Adolescent Violence Prevention treatment differ from other treatments for violence prevention?
This treatment is unique because it uses a Narrative Engagement Framework (NEF), which focuses on personal stories to engage adolescents in violence prevention. Unlike traditional methods, this approach emphasizes the active involvement of youth in creating and sharing narratives, potentially making the prevention efforts more relatable and effective.26789
Research Team
Patrick Carter, M.D.
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for healthcare providers like nurses and social workers at certain study sites who are involved in screening or delivering the SafERteens program. Providers starting work more than 9 months after implementation or those not expected to complete these tasks in their roles cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of the SafERteens program with engagement strategies to increase and sustain reach by healthcare providers
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Commitment
- Narrative Persuasion
- Personalized Feedback
- Reciprocity
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator